Can Patients Use HSA or FSA Cards for Peptide Therapy?

On this page 7 sections

1. When You Can Use an HSA for Peptide Therapy
2. A Card Approval Is Not an Eligibility Ruling
3. How Common Peptide Clinic Charges Sort
4. Why HSA Cards Decline at Peptide Clinics
5. Paperwork That Holds up With Plan Administrators
6. Itemize the Bill, Then Let the Patient Pick the Card
7. What Your Front Desk Should Say

Key takeaways

• When an HSA or FSA card is approved at a healthcare MCC, that only shows how your account is coded. Whether the peptide qualifies depends on the prescription, its purpose and where it came from.
• Peptides sold as research-use-only, cosmetic or "optimization" products don't meet the IRS definition of medical care, even when a clinic sells them.
• An HSA holder under 65 who pays for a non-qualified expense owes income tax plus a 20% additional tax. In our illustrative case, a $450 charge leads to $198 in federal tax.
• Splitting a bill into accurate line items so patients can pay each one with the right card is legitimate. Relabeling services to get plan cards approved is not.

Yes, patients can use an HSA for peptide therapy when a licensed provider prescribes the peptide to treat a diagnosed condition and a licensed pharmacy lawfully dispenses it. Peptides sold for longevity, appearance or general wellness don't qualify, and research-grade vials don't either. A card approval at your terminal settles nothing. It shows your clinic is coded as a healthcare merchant, not that the purchase was a qualified medical expense.

Patients carry the tax risk. Your clinic controls the things that decide whether their claim holds up: how your merchant account is coded, how each bill is itemized and what the prescriber puts in writing.

This is general information, not tax or legal advice. Patients should confirm eligibility with their plan administrator or a tax professional, and clinics should take prescribing and compounding questions to a healthcare attorney.

When You Can Use an HSA for Peptide Therapy

HSAs and health FSAs pay for medical care as the tax code defines it. The IRS's Topic No. 502 describes medical care as payments for the "diagnosis, cure, mitigation, treatment, or prevention of disease," or for treatments affecting a structure or function of the body. IRS Publication 969 says HSA distributions are tax-free when they pay qualified medical expenses, and it refers readers to Publication 502 for what those expenses are.

IRS Publication 502 is written for the itemized medical deduction. It defines a prescribed drug as one that needs a doctor's prescription for its use. HSA and FSA rules follow it closely, with one difference covered in the first point below. Three parts of the IRS guidance decide most peptide cases:

• Prescription status. A peptide your provider prescribes and a licensed pharmacy dispenses can count. Since the CARES Act, HSAs and FSAs can also pay for over-the-counter medicines without a prescription. Injectable and compounded peptides aren't sold over the counter, though, so in practice they need a valid prescription.
• Purpose. Section 213(d)(9) of the tax code excludes cosmetic procedures unless they correct a congenital abnormality, an injury from an accident or trauma, or a disfiguring disease. Peptides marketed for skin, hair or "anti-aging" fall on the wrong side of that rule.
• Source. Publication 502 says a prescribed drug ordered and shipped from another country generally doesn't count. There are narrow exceptions, such as drugs the FDA announces individuals can legally import.

Vials labeled "research use only" fail both routes. No prescription stands behind them, and a product labeled not for human use isn't sold as a medicine, over the counter or any other way. Our article on whether research-use-only labels protect your peptide merchant account covers how processors read those labels.

A prescription doesn't fix a sourcing problem, either. Federal and state regulators have scrutinized compounded peptides, and the list of bulk peptide ingredients pharmacies may compound keeps changing. Confirm the current status of each peptide you prescribe with your compounding pharmacy and your counsel.

A Card Approval Is Not an Eligibility Ruling

Clinics misread this rule more than any other. Plan cards are screened by merchant category code (MCC), the four-digit code your processor assigns to describe your business. IRS Notice 2007-2 describes card programs whose use "is limited to physicians, pharmacies, dentists, vision care offices, hospitals" and similar providers. If your account carries a healthcare MCC, the card is approved at the merchant level. Nobody checks whether the line item was a physician follow-up or a coaching add-on.

What happens after approval depends on the account.

FSAs review the charge later. Under Notice 2007-2, card charges are conditional until they're confirmed. The exceptions are matched copayments, recurring expenses and charges confirmed in real time through an inventory system. IRS Notice 2006-69 doesn't let patients self-certify an expense, as Trucker Huss's summary of the notice explains. If the receipt doesn't support the charge, Revenue Ruling 2003-43 requires the plan to recover the money and suspend the card until it's repaid. The patient's frustration over that usually lands at your front desk.

HSAs don't review it at all. No administrator looks at a receipt when the card is used. The account holder answers for the charge at tax time. Publication 969 says money not used for qualified medical expenses is subject to income tax and can carry an additional 20% tax, and 26 U.S.C. § 223(f)(4) sets that rate. The 20% tax doesn't apply after the account holder turns 65, becomes disabled or dies, but income tax still does.

Worked Example: What a Non-Qualified Charge Costs the Patient

These numbers are illustrative. Assume a patient who is 42, not disabled and in the 24% federal bracket pays $450 from an HSA for a three-month "longevity" peptide program with no diagnosed condition behind it. Later, the patient concludes it wasn't a qualified expense.

The patient owes $198 in federal tax, plus any state income tax, on money they thought was tax-free. That's why the words "HSA approved" should never appear on your signage or checkout page, and your staff should never say them.

How Common Peptide Clinic Charges Sort

Administrators judge each charge, not the clinic. Use this table as a front-desk reference, not a ruling on any patient's claim.

The same injection can land in either row depending on why it was prescribed. Train staff to talk about paperwork, not products.

Why HSA Cards Decline at Peptide Clinics

When a plan card declines, the cause is usually your merchant setup, not the patient's balance.

Processors publish the healthcare MCCs that can take HSA and FSA cards without extra certification. Paya's list includes 8011 (doctors and physicians, not elsewhere classified), 8021 (dentists and orthodontists), 8031 (osteopaths) and 8041 (chiropractors), among others. Plan cards will decline on an account coded as a spa, a beauty business or a general retailer.

Merchants outside those codes need SIGIS registration and an Inventory Information Approval System (IIAS), which flags eligible items at the product level, according to Finix's integration documentation. You may have read about an alternative called the 90% rule. It applies to drug stores and pharmacies, not clinics. If your practice is physician-led and coded that way, IIAS isn't the fix. If you also sell retail products through the same POS, ask your processor whether item-level flagging applies to you.

Accurate classification is the only legitimate route. Your MCC has to describe what the business actually does. Coding a wellness center or online peptide shop as a physician office to get plan cards approved is miscoding. It breaks card network rules and risks account termination and a MATCH listing. If your honest MCC means plan cards won't work, that's the correct outcome. Our guide to peptide therapy clinic payments, terminals and consults covers how underwriters view this vertical.

Other declines have simpler causes. If the plan balance is lower than the bill, use partial authorization: the card covers what's available and the patient pays the rest another way. If the plan year has ended or the card isn't active, the patient needs to call their administrator. Online checkouts need card-not-present transactions classified correctly, and our article on HSA and FSA cards for telehealth visits and prescriptions covers that side.

Paperwork That Holds up With Plan Administrators

A letter of medical necessity (LMN) comes from the prescribing provider, not the billing staff. Administrators set their own formats, but a useful letter includes:

• Patient name, plus the provider's name, credentials and contact details
• Diagnosed condition being treated
• Specific treatment prescribed and why it's medically necessary
• Expected duration or frequency
• Provider signature and date

Some administrators want LMNs renewed periodically, so set a renewal reminder for long-running protocols.

A card slip alone won't satisfy an FSA administrator. Give patients an itemized receipt or superbill showing:

• Clinic name, address and provider name
• Patient name and date of service
• Each service or product on its own line, described in plain words, with its price
• Which items were prescribed
• Payment method and amount paid with each

Include diagnosis information only when the patient asks for it for reimbursement, and follow your HIPAA obligations when you share it.

Itemize the Bill, Then Let the Patient Pick the Card

A single monthly "peptide membership" that bundles a visit, medication, coaching and supplements is nearly impossible to substantiate, and an administrator can reject the whole charge. Separate line items solve that.

Illustrative example: A visit includes a $150 provider follow-up, a $300 peptide prescribed for a documented diagnosis and a $120 coaching add-on. The clinic rings up three items. The patient puts $450 on an HSA card and $120 on a personal credit card. The receipt shows each line and which card paid for it.

Separating charges by category is legitimate because every charge is described accurately. Transaction splitting is something else. It means breaking one sale into smaller charges to dodge limits, avoid declines or disguise what was sold, and card networks prohibit it. Never relabel a wellness service as a medical visit.

To set this up on your POS system, create separate items for consultations, prescriptions and non-medical services, then turn on split tender and partial authorization. If you bill multi-week protocols, itemize each cycle; our guide to billing 8-week peptide protocols without recurring disputes shows how. If you run surcharging, cash discount or dual pricing, ask your processor how the program treats HSA and FSA cards, because network rules for debit and prepaid cards differ from the rules for credit cards.

What Your Front Desk Should Say

Give staff a short script and keep them out of tax advice:

• "We'll give you an itemized receipt, and your provider can write a letter of medical necessity if treatment is prescribed."
• "Your plan administrator decides what's eligible, so check with them before using plan funds."
• "A card approval doesn't mean the expense qualifies. Keep your receipts."
• "If your plan card declines, you can pay another way and submit for reimbursement if your plan allows it."

Online clinics should put the same guidance on the checkout page. Our article on HSA and FSA eligibility for supplements shows how the same questions apply to related products.

Your first move this week: pull your latest processing statement, find your MCC and check it against what your practice actually does. If the code is wrong, or your terminal can't split tender, MannyPay offers peptide industry merchant services and high-risk merchant accounts, subject to underwriting. Request a free processing quote, and a MannyPay specialist will respond within one business day.

Sources

1. Publication 502 (2025), Medical and Dental Expenses (IRS)
2. Topic No. 502, Medical and Dental Expenses (IRS)
3. Publication 969 (2025), Health Savings Accounts and Other Tax-Favored Health Plans (IRS)
4. 26 U.S.C. § 223, Health Savings Accounts
5. IRS Notice 2007-2, Amounts Received Under Accident and Health Plans
6. New Guidance on the Use of Electronic Payment Cards for Health FSAs, HRAs and DCAPs (Trucker Huss, on IRS Notice 2006-69)
7. FSA Debit Card (summary of Rev. Rul. 2003-43 recoupment and card suspension)
8. The HSA Distribution Rules: Part I (Newfront)
9. How to Accept FSA and HRA Cards (Paya/Nuvei, healthcare MCC list)
10. HSA / FSA Cards (Finix documentation)
11. IIAS vs 90% Comparison (SIGIS)
12. IRS Publication 502: What's Actually Reimbursable (SIMERP, on IRC §213(d)(9) and the CARES Act)
13. IRS Publication 502: Eligible Medical Expenses (LegalClarity, on supplements)

IC

About the author

Isabella Cruz

Isabella Cruz is Business Growth & Commerce Editor for Beyond the Swipe, writing for small businesses, restaurants, retailers, entertainment venues and e-commerce sellers.

This article is for general educational purposes and is not legal, tax or financial advice. Card network rules and state laws change; confirm current requirements for your business.